Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1040 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Actelion reports IPF drug study results

The study evaluated the efficacy and safety of the 10mg dose of macitentan or placebo in 178 patients with idiopathic pulmonary fibrosis. On average, patients were exposed to

Abbott, Eisai to debut PEI dug Lipacreon in Japan

When compared with Japanese Pharmacopoeia-listed pancreatin, the titer per unit weight of Lipacreon is approximately 8 times that of lipase, approximately 7 times that of protease and approximately

Astellas submits OAB drug application to FDA, EMA

Mirabegron is a once daily oral selective B3-adrenoceptor agonist discovered and developed by Astellas. The company is seeking approval for the indication of overactive bladder (OAB) associated with

Gentiva Health to sell remaining stake in CareCentrix

The company is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities

Xendo, Batavia in biopharma process collaboration

Under a business collaboration signed between the two companies, Batavia Bioservices will get access to simulated moving bed (SMB) purification technology as well as infrastructure, knowledge and experience